Shared Decision Making in Patients With Lung Cancer

This study is developing and testing a decision-support tool to help patients with lung cancer make an informed decision about whether to undergo molecular (genetic) testing of their tumor, which can identify targeted therapies. The study involves patients, surgeons, nurses, and other healthcare workers. **You may be eligible if...** - You are 18 or older and have been diagnosed with early-stage invasive lung adenocarcinoma (a type of lung cancer confirmed during or after surgery) - You are facing or have recently faced the decision of whether to undergo molecular testing - (For healthcare workers) You have relevant clinical experience and are willing to participate **You may NOT be eligible if...** - You are unable to understand the study content Talk to your doctor to see if this trial is right for you.